---
document_datetime: 2023-09-21 20:56:15
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/m-m-rvaxpro-epar-all-authorised-presentations_en.pdf
document_name: m-m-rvaxpro-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.8387326
conversion_datetime: 2025-12-15 00:31:27.446586
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form                                                   | Route of administration           | Immediate Packaging                                       | Content (concentration)   | Pack size                                         |
|------------------|-------------------|------------|-----------------------------------------------------------------------|-----------------------------------|-----------------------------------------------------------|---------------------------|---------------------------------------------------|
| EU/1/06/337/001  | M-M-RvaxPro       | --1        | Powder and solvent for suspension for injection                       | Subcutaneous or intramuscular use | powder: vial (glass); solvent: vial (glass)               | 0.5 mL                    | 1 vial + 1 vial                                   |
| EU/1/06/337/002  | M-M-RvaxPro       | --1        | Powder and solvent for suspension for injection                       | Subcutaneous or intramuscular use | powder: vial (glass); solvent: vial (glass)               | 0.5 mL                    | 10 vials + 10 vials                               |
| EU/1/06/337/005  | M-M-RvaxPro       | --1        | Powder and solvent for suspension for injection in pre-filled syringe | Subcutaneous or intramuscular use | powder: vial (glass); solvent: pre-filled syringe (glass) | 0.5 mL                    | 1 vial + 1 pre-filled syringe without needle      |
| EU/1/06/337/006  | M-M-RvaxPro       | --1        | Powder and solvent for suspension for injection in pre-filled syringe | Subcutaneous or intramuscular use | powder: vial (glass); solvent: pre-filled syringe (glass) | 0.5 mL                    | 10 vials + 10 pre- filled syringes without needle |
| EU/1/06/337/007  | M-M-RvaxPro       | --1        | Powder and solvent for suspension for injection in pre-filled syringe | Subcutaneous or intramuscular use | powder: vial (glass); solvent: pre-filled syringe (glass) | 0.5 mL                    | 20 vials + 20 pre- filled syringes without needle |
| EU/1/06/337/008  | M-M-RvaxPro       | --1        | Powder and solvent for suspension for injection in pre-filled syringe | Subcutaneous or intramuscular use | powder: vial (glass); solvent: pre-filled syringe (glass) | 0.5 mL                    | 1 vial + 1 pre-filled syringe + 1 needle          |
| EU/1/06/337/009  | M-M-RvaxPro       | --1        | Powder and solvent for suspension for injection in pre-filled syringe | Subcutaneous or intramuscular use | powder: vial (glass); solvent: pre-filled syringe (glass) | 0.5 mL                    | 10 vials + 10 pre- filled syringes + 10 needles   |

<div style=\"page-break-after: always\"></div>

| EU/1/06/337/010   | M-M-RvaxPro   | --1   | Powder and solvent for suspension for injection in pre-filled syringe   | Subcutaneous or intramuscular use   | powder: vial (glass); solvent: pre-filled syringe (glass)   | 0.5 mL   | 20 vials + 20 pre- filled syringes + 20 needles   |
|-------------------|---------------|-------|-------------------------------------------------------------------------|-------------------------------------|-------------------------------------------------------------|----------|---------------------------------------------------|
| EU/1/06/337/011   | M-M-RvaxPro   | --1   | Powder and solvent for suspension for injection in pre-filled syringe   | Subcutaneous or intramuscular use   | powder: vial (glass); solvent: pre-filled syringe (glass)   | 0.5 mL   | 1 vial + 1 pre-filled syringe + 2 needles         |
| EU/1/06/337/012   | M-M-RvaxPro   | --1   | Powder and solvent for suspension for injection in pre-filled syringe   | Subcutaneous or intramuscular use   | powder: vial (glass); solvent: pre-filled syringe (glass)   | 0.5 mL   | 10 vials + 10 pre- filled syringes + 20 needles   |
| EU/1/06/337/013   | M-M-RvaxPro   | --1   | Powder and solvent for suspension for injection in pre-filled syringe   | Subcutaneous or intramuscular use   | powder: vial (glass); solvent: pre-filled syringe (glass)   | 0.5 mL   | 20 vials + 20 pre- filled syringes + 40 needles   |
| EU/1/06/337/014   | M-M-RvaxPro   | --1   | Powder and solvent for suspension for injection                         | Subcutaneous or intramuscular use   | powder: vial (glass); solvent: vial (glass)                 | 0.5 mL   | 5 vials + 5 vials                                 |

- --1 Measles virus 1  Enders' Edmonston strain (live, attenuated) ……………………not less than 1x10 3  TCID 50* Mumps virus 1  Jeryl Lynn [Level B] strain (live, attenuated)  ……………… not less than 12.5x10 3  TCID 50* Rubella virus 2  Wistar RA 27/3 strain (live, attenuated) ……………………………not less than 1x10 3  TCID 50*

*50% tissue culture infectious dose

1  produced in chick embryo cells.

2  produced in WI-38 human diploid lung fibroblasts